viimane versioon :
16/02/2025
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Melphalan
keemiline struktuur
Kaubanduslikud nimed erinevates maades
Preparaatide nimed on näitlikud ja abianete sisaldus võib erineda sõltuvalt riigist ja laborist
Alkeran
Ameerika ühendriigid, Araabia Ühendemiraadid, Belgia, Brasiilia, Holland, Iirimaa, Iraan, Itaalia, Kanada, Kolumbia, Kreeka, Luksemburg, Malaisia, Prantsusmaa, Rootsi, Saksamaa, Sveits, Tšiili, uus-Meremaa
Egymelan
Maroko
Eriolan
Argentiina, Ecuador
Melfalan
Argentiina, Ecuador, Hispaania, Saksamaa, Tšiili
Melfoma
Argentiina, Maroko
Melkayl
Tšiili
Melphalan
Suurbritannia
Phelinun
Saksamaa
Viited : Melphalan
tüüp
avaldamine
84
ajaleht
Trissel LA, Martinez JF.
Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 495-499.
160
ajaleht
Pinguet F, Martel P, Rouanet P, Fabbro M, Astre C.
Effect of sodium chloride concentration and temperature on melphalan stability during storage and use.
Am J Hosp Pharm 1994 ; 51: 2701-2704.
169
ajaleht
Trissel LA, Martinez JF.
Physical compatibility of melphalan with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1993 ; 50: 2359-2363.
182
ajaleht
Trissel LA, Gilbert DL, Martinez JF.
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 56-60.
244
ajaleht
Trissel LA, Martinez JF.
Compatibility of filgrastim with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1907-1913.
307
ajaleht
Trissel LA, Martinez JF.
Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1792-1799.
854
ajaleht
Chang SY, Evans TL, Alberts DS.
The stability of melphalan in the presence of chloride ion.
J Pharm Pharmacol 1979 ; 31: 853-854.
905
ajaleht
Trissel LA, Martinez JF.
Screening teniposide for Y-site physical incompatibilities.
Hosp Pharm 1994 ; 29: 1010-1017.
1501
ajaleht
Beitz C, Bertsch T, Hannak D, Schrammel W, Einberger C, Wehling M.
Compatibility of plastics with cytotoxic drug solutions - comparison of polyethylene with other container materials.
Int J Pharm 1999 ; 185: 113-121.
1520
Labor
Etude de stabilité des médicaments en Ecoflac®
B Braun 2001
2247
ajaleht
Chan P, Heatherly K, Kupiec T.C, Trissel L.A.
Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2008 ; 12, 3: 276-278.
3516
plakat
Vigneron J, Zenier H, May I, Nicolas A.
Stabilité du melphalan à 2 mg/ml dans le chlorure de sodium 0,9% dans des conditions pratiques d'utilisation.
SFPO Congress, Mandelieu, France. 2013
3584
Labor
Melphalan (Alkéran®) - Résumé des caractéristiques du produit
Aspen Pharma 2013
3786
ajaleht
Buitrago E, Lagomarsino E; Mato G; Schaiquevich P.
Stability of Melphalan Solution for Intravitreal Injection for Retinoblastoma
JAMA Ophtalmology 2014 ; 132, 11: 1372-1373.
3949
plakat
Brönnimann C, Berger-Gryllaki M, Podilsky G, Sadeghipour F.
Optimisation du processus de préparation des solutions de melphalan destinées à l’administration intra-vitréenne dans le traitement du rétinoblastome et étude de leur stabilité
JFSPH Congress, Bern, Switzerland. 2016
3977
ajaleht
Desmaris R.P, Mercier L, Paci A.
Stability of Melphalan in 0,9% Sodium Chloride Solutions Prepared in Polyvinyl Chloride Bags for Intravenous Injection.
Drugs R D 2015 ;15:253-259.
4189
ajaleht
Kawedia J, Ramchandran S, Liu X, Gulbis A, Titus M, Bashir Q, Qazilbash M, Champlin R, Ciur S,
Stability of Captisol-enabled versus propylene glycol–based melphalan at room temperature and after refrigeration.
Am J Health-Syst Pharm 2022 ;79,12: 1011-1018
4376
ajaleht
Shi Z, Abruzzo T, Wanasathop A, Li S K.
Compatibility of Melphalan in Iodinated Contrast Media.
Int J Pharm Compound 2020 ;24,1:83-85
4701
ajaleht
Singh R, Chen J, Miller T, Bergren M, Mallik R.
Solution stability of Captisol-stabilized melphalan (Evomela) versus Propylene glycol-based melphalan hydrochloride injection.
Pharm Dev Technol 2018 ; 23, 10: 1024-1029.
Mentions Légales